Mechanistic Insight of Bivalent Compound 21MO as Potential Neuroprotectant for Alzheimer's Disease

Molecules

Volumn 21, Issue 4, 2016, Pages

  Saathoff, John M ^a   Liu, Kai ^a   Chojnacki, Jeremy E ^a   He, Liu ^a   Chen, Qun ^a   Lesnefsky, Edward J ^a   Zhang, Shijun ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Bivalent compound; Calcium; Mitochondria; Multifunctional; Neuroprotection

Indexed keywords

17MN COMPOUND; AMYLOID BETA PROTEIN; CALCIUM; CHOLESTEROL; CURCUMIN; NEUROPROTECTIVE AGENT;

ALZHEIMER DISEASE; ANALOGS AND DERIVATIVES; ANIMAL; CELL LINE; DRUG EFFECTS; ENDOPLASMIC RETICULUM; HUMAN; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NERVE CELL; PATHOLOGY; RISK FACTOR;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; CALCIUM; CELL LINE; CHOLESTEROL; CURCUMIN; ENDOPLASMIC RETICULUM; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; NEURONS; NEUROPROTECTIVE AGENTS; RISK FACTORS;

EID: 84968659753     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules21040412     Document Type: Article

References (19)

1. Alzheimer's Association. 2015 Alzheimer's disease facts and figures. Alzheimers Dement. 2015, 11, 332-384.
2. Hardy, J.; Selkoe, D.J. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 2002, 297, 353-356.
3. Kirkitadze, M.D.; Bitan, G.; Teplow, D.B. Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: The emerging role of oligomeric assemblies. J. Neurosci. Res. 2002, 69, 567-577.
4. Walsh, D.M.; Selkoe, D.J. A beta oligomers-A decade of discovery. J. Neurochem. 2007, 101, 1172-1184.
5. Selkoe, D.J. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav. Brain Res. 2008, 192, 106-113.
6. Bush, A.I. Drug development based on the metals hypothesis of Alzheimer's disease. J. Alzheimers Dis. 2008, 15, 223-240.
7. Zhu, X.; Su, B.; Wang, X.; Smith, M.A.; Perry, G. Causes of oxidative stress in Alzheimer disease. Cell. Mol. Life Sci. 2007, 64, 2202-2210.
8. Eckert, G.P.; Renner, K.; Eckert, S.H.; Eckmann, J.; Hagl, S.; Abdel-Kader, R.M.; Kurz, C.; Leuner, K.; Muller, W.E. Mitochondrial dysfunction-A pharmacological target in Alzheimer's disease. Mol. Neurobiol. 2012, 46, 136-150.
9. Viegas-Junior, C.; Danuello, A.; da Silva Bolzani, V.; Barreiro, E.J.; Fraga, C.A. Molecular hybridization: A useful tool in the design of new drug prototypes. Curr. Med. Chem. 2007, 14, 1829-1852.
10. Tietze, L.F.; Bell, H.P.; Chandrasekhar, S. Natural product hybrids as new leads for drug discovery. Angew. Chem. Int. Ed. 2003, 42, 3996-4028.
11. Carreiras, M.C.; Mendes, E.; Perry, M.J.; Francisco, A.P.; Marco-Contelles, J. The multifactorial nature of Alzheimer's disease for developing potential therapeutics. Curr. Top. Med. Chem. 2013, 13, 1745-1770.
12. Lenhart, J.A.; Ling, X.; Gandhi, R.; Guo, T.L.; Gerk, P.M.; Brunzell, D.H.; Zhang, S. "Clicked" bivalent ligands containing curcumin and cholesterol as multifunctional abeta oligomerization inhibitors: Design, synthesis, and biological characterization. J. Med. Chem. 2010, 53, 6198-6209.
13. Liu, K.; Gandhi, R.; Chen, J.; Zhang, S. Bivalent ligands targeting multiple pathological factors involved in Alzheimer's disease. ACS Med. Chem. Lett. 2012, 3, 942-946.
14. Chojnacki, J.E.; Liu, K.; Saathoff, J.M.; Zhang, S. Bivalent ligands incorporating curcumin and disogenin as multifunctional compounds against Alzheimer's disease. Biorg. Med. Chem. 2015, 23, 7324-7331.
15. Liu, K.; Chojnacki, J.E.; Wade, E.E.; Saathoff, J.M.; Lesnefsky, E.J.; Chen, Q.; Zhang, S. Bivalent compound
16. 17MN exerts neuroprotection through interaction at multiple sites in a cellular model of Alzheimer's disease. J. Alzheimers Dis. 2015, 47, 1021-1033.
17. Chojnacki, J.E.; Liu, K.; Yan, X.; Toldo, S.; Selden, T.; Estrada, M.; Rodriguez-Franco, M.I.; Halquist, M.S.; Ye, D.; Zhang, S. Discovery of 5-(4-hydroxyphenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl) -ethyl]-amide as a neuroprotectant for Alzheimer's disease by hybridization of curcumin and melatonin. ACS Chem. Neurosci. 2014, 5, 690-699.
18. Koopman, W.J.; Nijtmans, L.G.; Dieteren, C.E.; Roestenberg, P.; Valsecchi, F.; Smeitink, J.A.; Willems, P.H. Mammalian mitochondrial complex I: Biogenesis, regulation, and reactive oxygen species generation. Antioxid. Redox Signal. 2010, 12, 1431-1470.
19. Chinta, S.J.; Rane, A.; Yadava, N.; Andersen, J.K.; Nicholls, D.G.; Polster, B.M. Reactive oxygen species regulation by AIF- and complex I-depleted brain mitochondria. Free Radic. Biol. Med. 2009, 46, 939-947.